Paper
RSC Advances
Recently, Li et al.17 reported that the condensation of an
aldehyde, Meldrum’s acid and a functionalized HKA could give
rise to an imidazo(pyrido)[1,2-a]pyridine intermediate
2 C. Hamdouchi, J. Ezquerra, J. A. Vega, J. J. Vaquero,
J. Alvarez-Builla and B. A. Heinz, Bioorg. Med. Chem. Lett.,
1999, 9, 1391–1394.
D
3 A. Scribner, R. Dennis, J. Hong, S. Lee, D. McIntyre,
D. Perrey, D. Feng, M. Fisher, M. Wyvratt, P. Leavitt,
P. Liberator, A. Gurnett, C. Brown, J. Mathew,
D. Thompson, D. Schmatz and T. Biftu, Eur. J. Med.
Chem., 2007, 42, 1334–1357.
bearing a highly polarized push-pull interaction C–C double
bond and a Cl atom as a leaving group. The subsequent
intramolecular cyclization readily provided fused heterocycles
via an SNAr process (Scheme 1).17 To further expand the
applications and scope of the above-mentioned NHC-catalyzed
cascade cyclization, the following SNAr reaction was explored
(Table 3). After consumption of the HKAs with a chlorine atom
at the ortho-position with respect to the carbonyl group, the
solvent was replaced with DMF and the reaction mixture was
kept at 100 uC, yielding tetrahydrobenzo[b]imidazo[1,2,3-
ij][1,8]naphthyridines 5 in a smooth one-pot process.20b
On the basis of all the above results, two reasonable
pathways were proposed to account for the cyclization as
illustrated in Scheme 2.12,15c,15f,15g,17–19 Both pathways
involved in the formation of E at the beginning. On the one
hand, H was proposed as an intermediate derived from the
Claisen rearrangement of G, which was generated by the 1,2-
addition of E to F.15c,15f,19 On the other hand, the reaction
between E and F could lead to the formation of H directly,
through a 1,4-addition. The following intramolecular acylation
could then liberate the NHC catalyst and generate 3e.15g,18,19
Finally, an intramolecular SNAr reaction displacing the
o-chlorine of the aryl group due to attack of the NH group
gave the ultimate product 5g.12,17
4 (a) Z.-P. Zuang, M.-P. Kung, A. Wilson, C.-W. Lee, K. Plossl,
C. Hou, D. M. Holzman and H. F. Kung, J. Med. Chem.,
2003, 46, 237–243; (b) S. L. Colletti, J. L. Frie, E. C. Dixon, S.
B. Singh, B. K. Choi, G. Scapin, C. E. Fitzgerald, S. Kumar,
E. A. Nichols, S. J. O’Keefe, E. A. Neill, G. Porter, K. Samual,
D. M. Schmatz, C. D. Scwartz, W. L. Shoop, C.
M. Thompson, J. E. Thompson, R. Wang, A. Woods, D.
M. Zaller and J. B. Doherty, J. Med. Chem., 2003, 46,
349–352; (c) Z. T. Huang and M. X. Wang, J. Chem. Soc.,
Perkin Trans. 1, 1993, 1085–1090; (d) K. D. Bhoola, C.
D. Figueroa and K. Worthy, Pharmacol. Rev., 1992, 44, 1–80;
(e) Z. T. Huang and Z. R. Liu, Heterocycles, 1986, 24,
2247–2254.
5 (a) V. Aaberg and F. Almqvist, Org. Biomol. Chem., 2007, 5,
1827–1834; (b) J. S. Pinkner, H. Remaut, E. Miller,
V. Aaberg, N. Pemberton, M. Hedenstroem, A. Larsson,
P. Seed, G. Waksman, S. J. Hultgren and F. Almqvist, Proc.
Natl. Acad. Sci. U. S. A., 2006, 103, 17897–17902.
6 (a) M.-X. Zhao, M.-X. Wang and Z.-T. Huang, Tetrahedron,
2002, 58, 1309–1316; (b) R. C. F. Jones, P. Patel, S. C. Hirst
and M. J. Smallridge, Tetrahedron, 1998, 54, 6191–6200; (c)
R. C. F. Jones and M. J. Smallridge, Tetrahedron Lett., 1988,
29, 5005–5008; (d) K. Shiokawa, S. Tsuboi, S. Sasaki,
K. Moriya, Y. Hattori and K. Shibuya, EP 296453, 1988.
7 (a) K. Kubo, N. Ito, I. Souzu, Y. Isomura, H. Homma and
M. Murakami, US4284778A, 1981; (b) M. J. Frohn, F.-
T. Hong, L. Liu, P. Lopez, A. C. Siegmund, S. Tadesse and
N. Tamayo, WO 2005070932, 2005.
Conclusions
In conclusion, we have developed a new NHC-catalyzed
domino procedure as an alternative method for the synthesis
of bicyclic pyridones with different substituted patterns and
8 D. G. Hehemann and W. Winnik, J. Heterocycl. Chem., 1994,
31, 393–396.
tetrahydrobenzo[b]imidazo[3,2,1-ij][1,8]naphthyridines in
a
9 C.-Y. Yu, P.-H. Yang, M.-X. Zhao and Z.-T. Huang, Synlett,
2006, 1835–1840.
10 S. Chakrabarti, K. Panda, N. C. Misra, H. Ila and
H. Junjappa, Synlett, 2005, 1437–1441.
11 (a) H. Schirok, C. Alonso-Alijia, J. Benet-Buchnolz, A.
H. Goller, R. Grosseor, M. Michels and H. Paulsen, J. Org.
Chem., 2005, 70, 9463–9469; (b) M.-X. Wang, W.-S. Miao,
Y. Cheng and Z.-T. Huang, Tetrahedron, 1999, 55,
14611–14622; (c) Z. T. Huang and X. J. Wang, Tetrahedron
Lett., 1987, 28, 1527–1528.
one-pot process starting from a variety of HKAs and a-
bromoenals. A wide range of potential biologically active
nitrogen bridgehead-fused heterocycles for biomedical screen-
ing have been synthesized successfully.
Acknowledgements
We are grateful for financial support of NSFC (No. 21242014), a
project funded by the Priority Academic Program Development
of Jiangsu Higher Education Institutions, and the Major Basic
Research Project of the Natural Science Foundation of the
Jiangsu Higher Education Institutions (09KJA430003). This
project was also sponsored by Qing Lan Project (10qlg005).
12 M. Li, Z. M. Zhou, L. R. Wen and Z. X. Qiu, J. Org. Chem.,
2011, 76, 3054–3063.
13 For reviews, please see: (a) M. Fevre, J. Pinaud, Y. Gnanou,
J. Vignolle and D. Taton, Chem. Soc. Rev., 2013, 42,
2142–2172; (b) D. T. Cohen and K. A. Scheidt, Chem. Sci.,
2012, 3, 53–57; (c) Z. Q. Rong, W. Zhang, G. Q. Yang and S.
L. You, Curr. Org. Chem., 2011, 15, 3077–3090; (d) J.
L. Moore and T. Rovis, Top. Curr. Chem., 2010, 291, 77–144;
(e) V. Nair, S. B. Vellalath and P. Babu, Chem. Soc. Rev.,
2008, 37, 2691–2698; (f) D. Enders, O. Niemeier and
A. Henseler, Chem. Rev., 2007, 107, 5606–5655.
Notes and references
1 T. H. Al-Tel and R. A. Al-Qawasmeh, Eur. J. Med. Chem.,
2010, 45, 5848–5855.
14 (a) M. Schedler, D.-S. Wang and F. Glorius, Angew. Chem.,
Int. Ed., 2013, 52, 2585–2589; (b) B. Zhang, P. Feng, L.-
10804 | RSC Adv., 2013, 3, 10801–10805
This journal is ß The Royal Society of Chemistry 2013